A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy

Update Il y a 4 ans
Reference: NCT01245660

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Modification of the EGF signalling pathway and / or HER 2, by Lapatinib in bladder cancer.


Inclusion criteria

  • Bladder Carcinoma ,Infiltrative Bladder Carcinoma ,Cystectomy

Links